University of California San Francisco
Give to UCSF
Antiviral Drug Remdesivir Can Help Fight the Coronavirus, But Can Patients Get It?
Amid so little good news, early clinical trial results for the anti-viral drug remdesivir have offered hope. The drug appeared to help patients recover faster, from 15 days to 11 days. But the newest obstacle may be the uncertainty that surrounds how the drug will be distributed to patients.
Microbiome Therapy Protects Against Recurrent Bacterial Vaginosis
A product containing healthy vaginal bacteria has proved effective against recurrent bacterial vaginosis (BV), an extremely common vaginal infection that is associated with preterm birth, HIV infection and problems with in vitro fertilization.
Pricey Protocol Not Proven to Prevent or Reverse Alzheimer’s, Says UCSF Neurologist
The “Bredesen protocol” has reeled in patients and their families seeking hope outside of the physician’s office for a disease that is currently incurable, according to a UCSF cognitive neurologist.
Smoking Nearly Doubles the Rate of COVID-19 Progression
Smoking significantly worsens COVID-19, according to a new analysis by UCSF of the association between smoking and progression of the infectious disease.
2 UCSF Faculty to Lead New Research Institutes
Two UCSF faculty will lead the new institutes.
Resilience to ALS Due to Synaptic Safety Mechanism
UCSF researchers have identified a powerful self-corrective mechanism within synapses that is activated by neurodegeneration and acts to slow down disease progression in animal models of ALS.
Respiratory Infections May Drive Puerto Rico’s High Asthma Burden
New research confirmed the higher rates of early life respiratory infections among Puerto Ricans.
UC Hospitals Gradually Resume Essential Services Based on 10 Principles
The University of California’s hospitals announced a gradual resumption of essential services at all five medical centers across the state.
